Skip to main content
. 2021 Feb 26;13(5):6936–6944. doi: 10.18632/aging.202551

Figure 3.

Figure 3

bRFS outcome in patients treated with hypofractionated IG-VMAT versus conventionally fractionated IG-VMAT. bRFS, biochemical relapse–free survival; IG, imaging-guided; volumetric-modulated arc therapy, VMAT.